Portfolio company
Ankyra Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ancora Biotech
The company develops multi-specific antibody therapeutics to treat patients with cancer, inflammatory disorders, and chronic hepatitis B infections.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Bright Peak Therapeutics
This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.
Kymera Therapeutics
This biotechnology company develops small molecule medicines that degrade disease-causing proteins for patients with cancer and immune-inflammatory diseases.
Actym Therapeutics
This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.
Asher Biotherapeutics
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
